{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:44:17Z","timestamp":1791139457350,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.idc.2012.03.005","type":"journal-article","created":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T03:16:36Z","timestamp":1335237396000},"page":"309-322","source":"Crossref","is-referenced-by-count":247,"title":["Visceral Leishmaniasis"],"prefix":"10.1016","volume":"26","author":[{"given":"Johan","family":"van Griensven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermias","family":"Diro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idc.2012.03.005_bib1","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.idc.2012.03.005_bib2","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2012.03.005_bib3","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The relationship between leishmaniasis and AIDS: the second 10 years","volume":"21","author":"Alvar","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.idc.2012.03.005_bib4","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2012.03.005_bib5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","article-title":"Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda","volume":"2","author":"Guerin","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idc.2012.03.005_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1473-3099(03)00517-6","article-title":"Post-kala-azar dermal leishmaniasis","volume":"3","author":"Zijlstra","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idc.2012.03.005_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trstmh.2010.09.006","article-title":"Diagnosis of visceral leishmaniasis","volume":"105","author":"Srivastava","year":"2011","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.idc.2012.03.005_bib8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4269\/ajtmh.2005.73.269","article-title":"Detection of leishmanial antigen in the urine of patients with visceral leishmaniasis by a latex agglutination test","volume":"73","author":"Sundar","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.idc.2012.03.005_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/JCM.02029-06","article-title":"Molecular diagnosis of leishmaniasis: current status and future applications","volume":"45","author":"Reithinger","year":"2007","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.idc.2012.03.005_bib10","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1086\/518167","volume":"44","author":"Antinori","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2012.03.005_bib11","doi-asserted-by":"crossref","first-page":"858","DOI":"10.4269\/ajtmh.2006.75.858","article-title":"Reference values for Leishmania infantum parasitemia in different clinical presentations: quantitative polymerase chain reaction for therapeutic monitoring and patient follow-up","volume":"75","author":"Mary","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.idc.2012.03.005_bib12","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.4269\/ajtmh.2005.73.1012","article-title":"Value of culture and nested polymerase chain reaction of blood in the prediction of relapses in patients co-infected with leishmania and human immunodeficiency virus","volume":"73","author":"Riera","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.idc.2012.03.005_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0065-308X(05)61006-8","article-title":"Chemotherapy in the treatment and control of leishmaniasis","volume":"61","author":"Alvar","year":"2006","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.idc.2012.03.005_bib14","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1086\/507530","article-title":"Liposomal amphotericin B for the treatment of visceral leishmaniasis","volume":"43","author":"Bern","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2012.03.005_bib15","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1517\/13543784.17.5.787","article-title":"Paromomycin in the treatment of leishmaniasis","volume":"17","author":"Sundar","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.idc.2012.03.005_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/138955706775475993","article-title":"Development of miltefosine for the leishmaniases","volume":"6","author":"Berman","year":"2006","journal-title":"Mini Rev Med Chem"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2012.03.005_bib17","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.trstmh.2006.03.009","article-title":"Miltefosine\u2013discovery of the antileishmanial activity of phospholipid derivatives","volume":"100","author":"Croft","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.idc.2012.03.005_bib18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2174\/157489108786242341","article-title":"Visceral leishmaniasis: advances in treatment","volume":"3","author":"Maltezou","year":"2008","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"10.1016\/j.idc.2012.03.005_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.idc.2012.03.005_bib20","series-title":"Control of the leishmaniasis. Report of a meeting of\u00a0the WHO Expert Committee on the Control of Leishmaniases","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.idc.2012.03.005_bib21","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","article-title":"Drug resistance in Indian visceral leishmaniasis","volume":"6","author":"Sundar","year":"2001","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.idc.2012.03.005_bib22","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.3390\/ijerph7124267","article-title":"Antimony toxicity","volume":"7","author":"Sundar","year":"2010","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.idc.2012.03.005_bib23","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4269\/ajtmh.1985.34.702","article-title":"Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate)","volume":"34","author":"Chulay","year":"1985","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.idc.2012.03.005_bib24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4269\/ajtmh.1992.46.296","article-title":"Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies","volume":"46","author":"Herwaldt","year":"1992","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.idc.2012.03.005_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1086\/515085","article-title":"U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis","volume":"28","author":"Meyerhoff","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2012.03.005_bib26","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/377542","article-title":"Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study","volume":"37","author":"Sundar","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2012.03.005_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.trstmh.2006.02.005","article-title":"Unresponsiveness to AmBisome in some Sudanese patients with kala-azar","volume":"101","author":"Mueller","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.idc.2012.03.005_bib28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.trstmh.2008.09.008","article-title":"Paromomycin","volume":"103","author":"Davidson","year":"2009","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.idc.2012.03.005_bib29","doi-asserted-by":"crossref","first-page":"e709","DOI":"10.1371\/journal.pntd.0000709","article-title":"Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial","volume":"4","author":"Hailu","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.idc.2012.03.005_bib30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","article-title":"Combination therapy for visceral leishmaniasis","volume":"10","author":"van Griensven","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idc.2012.03.005_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.trstmh.2007.08.006","article-title":"Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment","volume":"102","author":"Musa","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.idc.2012.03.005_bib32","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1086\/318135","article-title":"HIV and leishmania coinfection: a review of 91 cases with focus on atypical locations of leishmania","volume":"31","author":"Rosenthal","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2012.03.005_bib33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4269\/ajtmh.1998.59.155","article-title":"The role of serology in the diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type-1","volume":"59","author":"Medrano","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.idc.2012.03.005_bib34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00005792-200101000-00006","article-title":"Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study","volume":"80","author":"Pintado","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.idc.2012.03.005_bib35","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1093\/cid\/cir521","article-title":"Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in bihar, India","volume":"53","author":"Sinha","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2012.03.005_bib36","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1086\/505217","article-title":"A\u00a0comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection","volume":"43","author":"Ritmeijer","year":"2006","journal-title":"Clin Infect Dis"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552012000141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552012000141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T19:42:35Z","timestamp":1561664555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552012000141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0891552012000141"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2012.03.005","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}